title: Practical considerations in the use of intravenous tacrolimus in hematopoietic stem cell transplantation patients.
authors.affiliation: Department of Pharmacy, Ghent University Hospital, Ghent, Belgium tiene.bauters@uzgent.be.
authors.forename: Tiene
authors.initials: T
authors.lastname: Bauters
authors.affiliation: Department of Pharmacy, Children's Hospital Michigan, Detroit, MI, USA.
authors.forename: Patricia
authors.initials: P
authors.lastname: Rayner
authors.affiliation: Department of Pharmacy, CHU Sainte-Justine, Montreal, Canada.
authors.forename: Roxane
authors.initials: R
authors.lastname: Therrien
authors.affiliation: Department of Pediatric Hemato-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium.
authors.forename: Sophie
authors.initials: S
authors.lastname: Van Lancker
authors.affiliation: Department of Pediatric Hemato-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium.
authors.forename: Victoria
authors.initials: V
authors.lastname: Bordon
authors.affiliation: Department of Pharmacy, Ghent University Hospital, Ghent, Belgium.
authors.forename: Marion
authors.initials: M
authors.lastname: Le Cordroch
authors.affiliation: Department of Pediatric Hemato-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium.
authors.forename: Catharina
authors.initials: C
authors.lastname: Dhooge
authors.affiliation: Department of Pediatric Hemato-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium.
authors.forename: Yves
authors.initials: Y
authors.lastname: Benoit
authors.affiliation: Department of Pharmacy, Ghent University Hospital, Ghent, Belgium.
authors.forename: Johan
authors.initials: J
authors.lastname: Vandenbroucke
mesh_terms: D061605:Administration, Intravenous; D006086:Graft vs Host Disease / Q000517:prevention & control; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016559:Tacrolimus / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D016559:Tacrolimus